CervoMed Inc.
Canonical company identity and public leadership record.
- Source reported. 26 claims from 3 sources.
- Not claimed by the company.
- Eval: not assessed.
- CEO
- John Alam
- Chair
- Not published
- Board
- 8 directorsAlpha calculation. Published seats
- Independence
- 6 of 8Alpha calculation
- Committees
- 5
- Evidence
- 3 sources26 published claims
- Open conflicts
- 0None open
Leadership
6 claims| Person | Role | Since | Status | Evidence |
|---|---|---|---|---|
| John Alam | President and Chief Executive Officer | Current | Source reportedE3 | |
| Kelly Blackburn | Executive Vice President, Clinical Development | Current | Source reportedE4 | |
| Marco Verwijs | Executive Vice President, Technical Operations | Current | Source reportedE5 | |
| Mark De Rosch | Executive Vice President, Regulatory and Government Affairs and Program Management | Current | Source reportedE6 | |
| Matthew Winton | Chief Commercial and Business Officer | Current | Source reportedE7 | |
| William R. Elder | Chief Financial Officer, General Counsel, Corporate Secretary | Current | Source reportedE8 |
Board
8 claims| Director | Status | Since | Committees | Evidence |
|---|---|---|---|---|
| Frank Zavrl | Independent | Audit; Audit; Compensation · Chair; Nominating and Governance; Compensation, chair; Nominating and Governance | Source reportedE2 | |
| Jane H. Hollingsworth, J.D. | Independent | None published | Source reportedE2 | |
| Jeff Poulton | Independent | Audit, chair; Audit · Chair; Compensation; Compensation | Source reportedE2 | |
| John Alam, M.D. | Not independent | None published | Source reportedE2 | |
| Joshua S. Boger, Ph.D. | Independent | None published | Source reportedE2 | |
| Marwan Sabbagh, M.D. | Independent | None published | Source reportedE2 | |
| Robert J. Cobuzzi, Jr., Ph.D. | Not independent | None published | Source reportedE2 | |
| Sylvie Grégoire, PharmD. | Independent | None published | Source reportedE2 |
Committees
8 claims| Committee | Chair | Members | Risks assigned | Evidence |
|---|---|---|---|---|
| Audit | Jeff Poulton | Jeff Poulton, Frank Zavrl | Not described in the published record | Source reportedE9 |
| Audit · Chair; Compensation | Not published | Jeff Poulton | Not described in the published record | |
| Audit; Compensation · Chair; Nominating and Governance | Not published | Frank Zavrl | Not described in the published record | |
| Compensation | Frank Zavrl | Frank Zavrl, Jeff Poulton | Not described in the published record | Source reportedE9 |
| Nominating and Governance | Not published | Frank Zavrl | Not described in the published record | Source reportedE9 |
| Fact | Stated value | Evidence |
|---|---|---|
| Committee appointment | Jeff Poulton: chair, Audit | Source reportedE9 |
| Committee appointment | Frank Zavrl: member, Audit | Source reportedE9 |
| Committee appointment | Frank Zavrl: chair, Compensation | Source reportedE9 |
| Committee appointment | Jeff Poulton: member, Compensation | Source reportedE9 |
| Committee appointment | Frank Zavrl: member, Nominating and Governance | Source reportedE9 |
Financial context
1 claim| Fact | Stated value | Evidence |
|---|---|---|
| Security listing | CRVO (NASDAQ) | Source reportedE1 |
Other published claims
3 claims| Fact | Stated value | Evidence |
|---|---|---|
| Legal name | CervoMed Inc. | Source reportedE1 |
| Entity status | Public listing published | Source reportedE1 |
| Published fact | US | Source reportedE1 |
Evidence
9 evidence records| Ref | Source | Authority | Source date | Retrieved | Rights | Cited by |
|---|---|---|---|---|---|---|
| E1 | Alpha canonical company public projectionCanonical identity | Open web | Not recorded | Rights not recorded, link only | 4 claims | |
| E2 | CervoMed Inc. DEF 14A 2025-04-29SEC proxy | Authoritative, regulatory filing | Rights not recorded, link only | 8 claims | ||
| E3 | CRVO DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E4 | CRVO DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E5 | CRVO DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E6 | CRVO DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E7 | CRVO DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E8 | CRVO DEF 14A executive officersSEC filing | Authoritative, regulatory filing | Rights not recorded, link only | 1 claim | ||
| E9 | Auditboard_seats. Board seats | Authoritative, regulatory filing | Not recorded | Not recorded | Rights not recorded, link only | 8 claims |
No evidence record is pinned or signed yet.
Not yet in this record
These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.
- Control and voting
- Governance
- Risk
- AI oversight
- Legal
- Compensation
Index memberships
No current membership is published in Alpha's tracked index universe.
This is not evidence that the company is absent from every market index.
As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Coverage states the record reports (12)
- Corporate structure
- Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- Ownership
- Not reviewed. Ownership and voting power determine who can influence the board.
- Financials
- Not reviewed. Governance-relevant financial context frames capital and audit decisions.
- Compensation
- Not reviewed. Pay design shows how incentives are governed.
- Governance
- Not reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governance
- Not reviewed. Meeting and vote records show shareholder dissent and support.
- Audit
- Not reviewed. Auditor, controls and restatements show assurance over reporting.
- Legal
- Not reviewed. Material legal and regulatory matters show enforcement exposure.
- Risk
- Not reviewed. Risk ownership links the board, committees, executives and controls.
- Cyber
- Not reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governance
- Not reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets external
- Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
History
Version public-1Published .
- CEO role recorded. John Alam executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
- Executive appointed. Kelly Blackburn executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
- Executive appointed. Marco Verwijs executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
- Executive appointed. Mark De Rosch executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
- Executive appointed. Matthew Winton executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
- CFO role recorded. William R. Elder executive of CervoMed Inc., effective 30 Apr 2026.Effective . Recorded .
- Director appointed. Joshua S. Boger, Ph.D. seat on CervoMed Inc., effective 2024.Effective . Recorded .
- Director appointed. Frank Zavrl seat on CervoMed Inc., effective 2023.Effective . Recorded .
- Director appointed. Jeff Poulton seat on CervoMed Inc., effective 2023.Effective . Recorded .
- Director appointed. John Alam, M.D. seat on CervoMed Inc., effective 2023.Effective . Recorded .
- Director appointed. Marwan Sabbagh, M.D. seat on CervoMed Inc., effective 2023.Effective . Recorded .
- Director appointed. Robert J. Cobuzzi, Jr., Ph.D. seat on CervoMed Inc., effective 2023.Effective . Recorded .
- Director appointed. Sylvie Grégoire, PharmD. seat on CervoMed Inc., effective 2023.Effective . Recorded .
- Committee created. Audit · Chair; Compensation committee of CervoMed Inc., effective 2023.Effective . Recorded .
- Committee member added. Jeff Poulton member of Audit · Chair; Compensation, effective 2023.Effective . Recorded .
- Committee created. Audit; Compensation · Chair; Nominating and Governance committee of CervoMed Inc., effective 2023.Effective . Recorded .
- Committee member added. Frank Zavrl member of Audit; Compensation · Chair; Nominating and Governance, effective 2023.Effective . Recorded .
- Director appointed. Jane H. Hollingsworth, J.D. seat on CervoMed Inc., effective 2020.Effective . Recorded .
About this record
- Alpha ID
- alpha:company:6dfa9495-6e2f-4407-930d-b5c8cfd450cc
- Version
- public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
- Identity
- Not claimed
- Evidence
- Source reported
- Evaluation
- Not assessed
- Monitoring
- Not monitored yet
- Authority
- Not published
- Freshness
- Current
- Integrity
- Not signed yet
- Basis
- Published company record built from public sources
- Never published
- Private company data: deployments, authority grants, TrustChecks, receipts, telemetry
The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.

